tirzepatide surpass 2 Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 Overview of the SURPASS clinical
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
![tirzepatide surpass 2 Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 Overview of the SURPASS clinical](https://www.researchgate.net/publication/364586639/figure/tbl2/AS:11431281091822132@1666625095022/Overview-of-the-SURPASS-clinical-trial-program-with-tirzepatide-in-the-therapy-of-type-2.png)
![tirzepatide surpass 2 Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 Overview of the SURPASS clinical](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13300-023-01398-1/MediaObjects/13300_2023_1398_Fig1_HTML.png)
![tirzepatide surpass 2 Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 Overview of the SURPASS clinical](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-024-02147-9/MediaObjects/12933_2024_2147_Fig1_HTML.png)
![tirzepatide surpass 2 Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 Overview of the SURPASS clinical](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01733-2/MediaObjects/41591_2022_1733_Fig1_HTML.png)























